Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01823549 · ClinicalTrials.gov registry record

Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients

A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
109
Enrollment target

NCT01823549 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 109 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01823549 has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
109 participants
Enrollment target

Study Summary

This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.

Interventions

  • OTHER questionnaire administration

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2002-12-11
Est. Completion 2024-12-31

What the Registry Record Tells You About NCT01823549

The ClinicalTrials.gov registry entry for NCT01823549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which questionnaire administration is the first listed.

NCT01823549 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01823549 about?

NCT01823549 is a clinical study titled "Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients". This study was a survey to determine the frequency of Complementary and Alternative Medicine (CAM) use in patients recently diagnosed with breast or prostate cancer who were starting radiation therapy. The survey was repeated at three time points to assess changes in CAM use over time.

What is the current status of trial NCT01823549?

This trial is currently completed. The enrollment target is 109 participants. The study started on 2002-12-11. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT01823549?

The interventions under investigation include: questionnaire administration (OTHER).

Who is sponsoring clinical trial NCT01823549?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.